Lynette M. Moore

1.2k total citations
12 papers, 899 citations indexed

About

Lynette M. Moore is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lynette M. Moore has authored 12 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Lynette M. Moore's work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Lynette M. Moore is often cited by papers focused on Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Lynette M. Moore collaborates with scholars based in United States, China and Russia. Lynette M. Moore's co-authors include Lawrence A. Donehower, Melissa Dumble, Wei Zhang, Margaret A. Goodell, Gary Van Zant, Stuart M. Chambers, Hartmut Geiger, Yu Ren, Chunsheng Kang and Baoli Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Lynette M. Moore

12 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynette M. Moore United States 10 648 481 175 146 85 12 899
Bill H. Diplas United States 14 603 0.9× 369 0.8× 135 0.8× 401 2.7× 50 0.6× 27 1.2k
Shannon Matheny United States 11 451 0.7× 389 0.8× 306 1.7× 225 1.5× 38 0.4× 36 1.0k
James A. Grunkemeyer United States 11 576 0.9× 202 0.4× 106 0.6× 68 0.5× 26 0.3× 17 1.0k
Hiromasa Tsuiki Japan 13 521 0.8× 157 0.3× 202 1.2× 128 0.9× 35 0.4× 20 903
Yueli Cui China 10 621 1.0× 187 0.4× 143 0.8× 67 0.5× 22 0.3× 13 920
Siv Beckman Sweden 11 473 0.7× 486 1.0× 199 1.1× 50 0.3× 41 0.5× 11 833
Matthias M. Feldkamp Canada 13 528 0.8× 212 0.4× 226 1.3× 323 2.2× 29 0.3× 18 1.1k
Michel Herranz Spain 14 1.0k 1.6× 322 0.7× 223 1.3× 65 0.4× 47 0.6× 16 1.2k
Demirkan Gursel United States 19 491 0.8× 284 0.6× 270 1.5× 243 1.7× 34 0.4× 32 970
Anke Waha Germany 19 967 1.5× 213 0.4× 166 0.9× 215 1.5× 28 0.3× 29 1.2k

Countries citing papers authored by Lynette M. Moore

Since Specialization
Citations

This map shows the geographic impact of Lynette M. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette M. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette M. Moore more than expected).

Fields of papers citing papers by Lynette M. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette M. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette M. Moore. The network helps show where Lynette M. Moore may publish in the future.

Co-authorship network of co-authors of Lynette M. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette M. Moore. A scholar is included among the top collaborators of Lynette M. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette M. Moore. Lynette M. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Moore, Lynette M. & Wei Zhang. (2015). MIR-491: CDKN2A tumor suppressor co-pilot. Oncoscience. 2(10). 825–826. 5 indexed citations
2.
Zhang, Chunzhi, Lynette M. Moore, Xia Li, W. K. Alfred Yung, & Wei Zhang. (2013). IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma. Neuro-Oncology. 15(9). 1114–1126. 110 indexed citations
3.
Moore, Lynette M., Yuexin Liu, Matti Annala, et al.. (2012). Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. The Journal of Pathology. 229(3). 449–459. 22 indexed citations
4.
Annala, Matti, Corrine Ying Xuan Chua, Sarah M. Dunlap, et al.. (2012). Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network. Proceedings of the National Academy of Sciences. 109(9). 3475–3480. 96 indexed citations
5.
Moore, Lynette M., et al.. (2011). Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model. Chinese Journal of Cancer. 30(3). 163–172. 1 indexed citations
6.
Zhou, Xuan, Yu Ren, Lynette M. Moore, et al.. (2010). Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Laboratory Investigation. 90(2). 144–155. 296 indexed citations
7.
Moore, Lynette M. & Wei Zhang. (2010). Targeting miR-21 in glioma: a small RNA with big potential. Expert Opinion on Therapeutic Targets. 14(11). 1247–1257. 43 indexed citations
8.
Moore, Lynette M., Sarah M. Smith, Ying Wu, et al.. (2009). IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proceedings of the National Academy of Sciences. 106(39). 16675–16679. 45 indexed citations
9.
Moore, Lynette M., Xiongbin Lu, Nader Ghebranious, Stuart D. Tyner, & Lawrence A. Donehower. (2007). Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity. Mechanisms of Ageing and Development. 128(11-12). 717–730. 28 indexed citations
10.
Gatza, Catherine E., Lynette M. Moore, Melissa Dumble, & Lawrence A. Donehower. (2007). Tumor Suppressor Dosage Regulates Stem Cell Dynamics during Aging. Cell Cycle. 6(1). 52–55. 26 indexed citations
11.
Dumble, Melissa, Lynette M. Moore, Stuart M. Chambers, et al.. (2006). The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 109(4). 1736–1742. 190 indexed citations
12.
Moore, Lynette M., Sundaresan Venkatachalam, Hannes Vogel, et al.. (2003). Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis. Oncogene. 22(49). 7831–7837. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bill H. Diplas Breakdown of academic impact, for papers by Shannon Matheny Breakdown of academic impact, for papers by James A. Grunkemeyer Breakdown of academic impact, for papers by Hiromasa Tsuiki Breakdown of academic impact, for papers by Yueli Cui Breakdown of academic impact, for papers by Siv Beckman Breakdown of academic impact, for papers by Matthias M. Feldkamp Breakdown of academic impact, for papers by Michel Herranz Breakdown of academic impact, for papers by Demirkan Gursel Breakdown of academic impact, for papers by Anke Waha
Rankless by CCL
2026